Ninety-nine durably suppressed HIV-infected patients had a coronary artery disease risk assessment and C-reactive protein (CRP) levels measured after an average of 42 months of indinavir-based highly active antiretroviral therapy (HAART). Pre-HAART CRP levels were determined for 79 patients, and an additional CRP value was obtained after an average of 31 additional months of HAART in 56. CRP levels were elevated but tended to be stable or decrease with indinavir-based HAART over extended periods of exposure.
|Original language||English (US)|
|Number of pages||4|
|State||Published - Dec 3 2004|